Pharyngeal Carcinoma — Trials

Pharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 357
Recruiting: 191
Ph III recruiting: 58
Growth YoY: +6.7%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 31.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (85)

clinicaltrialsPublishedShowing 1–18 of 18 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05955105	A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies	unknown	Phase 1 / Phase 2	200	Innolake BiopharmINDUSTRY	1	May 21, 2024	clinicaltrials
NCT04522050	Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma	unknown	Phase 1	65	Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER	1	Jul 12, 2023	clinicaltrials